Abstract
Purpose
We sought to imitate angiographic cerebral circulation time (CCT) and create a similar index from baseline CT perfusion (CTP) to better predict vasospasm in patients with subarachnoid hemorrhage (SAH).
Methods
Forty-one SAH patients with available DSA and CTP were retrospectively included. The vasospasm group was comprised of patients with deterioration in conscious functioning and newly developed luminal narrowing; remaining cases were classified as the control group. The angiography CCT (XA-CCT) was defined as the difference in TTP (time to peak) between the selected arterial ROIs and the superior sagittal sinus (SSS). Four arterial ROIs were selected to generate four corresponding XA-CCTs: the right and left anterior cerebral arteries (XA-CCTRA2 and XA-CCTLA2) and right- and left-middle cerebral arteries (XA-CCTRM2 and XA-CCTLM2). The CCTs from CTP (CT-CCT) were defined as the differences in TTP from the corresponding arterial ROIs and the SSS. Correlations of the different CCTs were calculated and diagnostic accuracy in predicting vasospasm was evaluated.
Results
Intra-class correlations ranged from 0.96 to 0.98. The correlations of XA-CCTRA2, XA-CCTRM2, XA-CCTLA2, and XA-CCTLM2 with the corresponding CT-CCTs were 0.64, 0.65, 0.53, and 0.68, respectively. All CCTs were significantly prolonged in the vasospasm group (5.8–6.4 s) except for XA-CCTLA2. CT-CCTA2 of 5.62 was the optimal cut-off value for detecting vasospasm with a sensitivity of 84.2% and specificity 82.4%
Conclusion
CT-CCTs can be used to interpret cerebral flow without deconvolution algorithms, and outperform both MTT and TTP in predicting vasospasm risk. This finding may help facilitate management of patients with SAH.
Introduction
Endovascular treatment has been proven to be safe for patients with aneurysmal subarachnoid hemorrhage (SAH) [1]. However, despite successful management of ruptured aneurysms, vasospasm eventually develops and causes morbidity in 20–34% of patients [2, 3]. Therefore, early identification of patients at risk for vasospasm deserves attention so that timely treatment with angioplasty or intra-arterial administration of calcium channel blockers to improve neurologic outcomes can be considered [4, 5]. The incidence of vasospasm varies from 16–70% according to the criteria used: lowest when only clinical symptoms are considered and increasing when other criteria such as digital subtraction angiography (DSA) or transcranial Doppler are considered [6]. Delayed cerebral ischemia, defined as symptomatic vasospasm when confirmed by infarcted lesions on CT scans, effectively predicts mortality and severe disability at three months, but cannot be used in early stages to identify patients at risks [7].
An angiographic vasospasm is a newly developed luminal narrowing of intracranial vasculature in post-SAH control angiographies [6, 8]. Prolonged angiographic cerebral circulation time (CCT) upon admission is a risk factor for post-SAH vasospasm [8]. Angiographic CCT refers to the time difference between time to peak (TTP) for the cavernous ICA and the parietal vein, representing the time needed for blood to pass the brain parenchyma [9]. In addition to identifying vasospasm, quantitative angiographic CCT has proven to be robust in monitoring peritherapeutic intracranial hemodynamic changes in the endovascular treatment of stenotic-occlusive disease and carotid-cavernous fistula [10–14]. The major advantage of this application is its rapid processing within the angiosuite. Previously acquired standard DSA series can be used for analysis without extra radiation exposure and contrast medium administration.
CT perfusion (CTP) can detect cerebral perfusion deficits related to vasospasm. Decreased cerebral blood flow (CBF) and increased mean transit time (MTT) are the most useful indicators with a pooled sensitivity of 73%, and specificity of 93% [15]. Sanelli et al. showed that CTP on admission can predict the likelihood of subsequent vasospasm with sensitivity of 50–60%, and specificity of 70–91% [16]. Nevertheless, CTP is vulnerable to inter-observer variability at several points, including selection of ROIs, arterial input function and different de-convolution methods [17, 18]. In cases of acute stroke, perfusion mismatch deficits are remarkably decreased and thus accurate results can be automatically generated from various types of datasets [19]. In most cases of vasospasm, the disturbance of CCT occurs in small intracranial arteries, making the application of optimal cut-off values in CTP to differentiate vasospasm from control groups particularly challenging due to the subtle nature of the changes [3, 20].
Given reliable prediction of vasospasm by angiographic CCT (intra-arterial injection), we wondered whether the CCT derived from CTP (intra-venous injection) could serve as an immediate surrogate hemodynamic marker to predict future likelihood of vasospasm. Therefore, we conducted the current study to explore the relationship between CCTs defined by CTP and DSA, and to further test the feasibility of using different CCTs to predict subsequent SAH-related vasospasm.
Materials and Methods
Patient population
One-hundred and thirty–two patients with non-traumatic SAH were recruited. All patients received CT Angiography and CTP at the emergency service center. The average time interval between their visits and CTP was 2.8 hours, ranging from 2 to 6 hours. Forty-six cases with uncertain aneurysm locations received DSA for further evaluation. Forty-one cases with both diagnostic CTP and DSA images available and acquired within a 24-hour interval were enrolled in our study. All of these cases underwent surgical clippings and received control angiography or CT angiography. They were further divided into two groups: the vasospasm group was defined to include patients with clinical deterioration on the Glasgow Coma Scale (GCS) of more than 2 points, evidenced by newly developed luminal narrowing of intracranial vessels in either subsequent DSA or CTA, and after excluding other etiologies such as hydrocephalus, electrolyte imbalance or sedative overdose [3, 6, 8]. Remaining cases were included in the control group. All cases in the control group also received CTP on admission. The patients’ initial GCS scores, Fisher grades and follow-up CT scans were reviewed. Any infarcts on the CT scans correlated with the territory of the vasospasm were considered to be delayed cerebral ischemia. This study was approved by Institutional Review Board of Taipei Veterans General Hospital and all participants gave their written informed consent.
DSA
All angiographies were performed in one flat-panel angiography machine (AXIOM-Artiszee®, Siemens Healthcare). A 4-French angiocatheter was placed at the level of the C4 vertebral body for the DSA. A fixed DSA imaging acquisition protocol, as previously reported by Lin et al [21] was used. Post-processing software (syngo iFlow®, Siemens Healthcare) was used to measure cerebral CCT based on time to peak (TTP) measurement with region of interest (ROI) placement on DSA [22]. The TTP for any selected ROI was defined as the time point at which the attenuation of the X-ray reached a maximum along the angiographic time frames. The reference time point, t = 0, was defined as the imaging time point of the selected DSA mask frame. A lateral view DSA was used for ROI selection to avoid confounding vasculature overlapping. On the right carotid artery DSA, a ROI was placed at the greatest curvature of the right ACA and named ROIRA2. An imaginary line parallel to the osteomeatal line was drawn to intersect the superior sagittal sinus (SSS) and the insular branch of the right-middle cerebral artery. Accordingly, the intersections were defined as ROIsss and ROIRM2, respectively (Fig 1A). The CCT measured on X-ray DSA (XA-CCT) was defined as the difference in TTP between the measured arterial ROI and the venous ROI. Therefore, two XA-CCTs (XA-CCTRA2 and XA-CCTRM2) were generated, based on the different arterial ROIs (ROIRA2 and ROIM2) selected in the ipsilateral DSA series (Fig 1B). Two additional XA-CCTs were generated (XA-CCTLA2 and XA-CCTLM2) from the left carotid artery DSA with the same measurement. ROI diameters were calculated so as to cover the calibers of the selected vessels without including imaging pixels outside the vessels [21]. One neuroradiologist and one angiographic technician with five years of experience in quantitative DSA, both unaware of the clinical conditions of the patients, analyzed all of the DSA datasets independently.
CTP
CT angiography and CTP were performed in a multislice CT (Brillance® CT, Philips Healthcare, Cleveland, USA). A total of 50 ml contrast (Ultravist® 370; Bayer, Berlin, Germany) was injected via the right antecubital vein at a rate of 5 ml/s, followed by a 20 ml bolus flush of normal saline. The acquisition parameters were: 80 kVp, 100 mAs, and a 1 second fixed-scan interval that lasted 1 min. We positioned patients to ensure that the axial scans were parallel to the osteomeatal line during the CTP. The scan range started 2 cm above the tuberculum sellae to cover a 4 cm upward scanning range. The whole dataset was sent to a dedicated workstation (EBW®4.5 Philips Healthcare, Cleveland, USA) to generate cerebral blood volume (CBV), cerebral blood flow (CBF), mean transit time (MTT), and time to peak (TTP). Due to the spatial resolution on the CTP imaging, the observer located only the dominant ACA at the slice where it curved anteriorly–posteriorly. Two additional arterial ROIs located at the insular branches of the right and left-middle cerebral arteries at the same slice were selected, accordingly. The venous ROI was placed at the SSS on the same slice (Fig 2A). The time density curve (TDC) was generated after determining the arterial and venous ROIs (Fig 2B). Three CT circulation times (CT-CCT), namely, CT-CCTA2, CT-CCTRM2 and CT-CCTLM2, were generated based on the time difference between the TTP values of the selected arterial and venous ROIs mentioned above. One neuroradiologist with 10 years of experience with CTP and one CT technician with 7 years of experience, both unaware of the clinical conditions of the patients, independently analyzed all of the CTP datasets.
Statistics
Intraclass correlation coefficients (ICC) for the measurements of the two observers were calculated for all Tmax, TTPs, CT-CCTs and XA-CCTs. Whenever there was a discrepancy, the average was used for further analysis. Pearson correlation coefficients between the three CT-CCTs, four XA-CCTs, and the GCS were calculated to verify the consistency of the CCTs. All CCTs and perfusion parameters for the vasospasm and control groups were compared using Student’s t-test. We used receiver operating characteristic curves (ROC) to evaluate the diagnostic performance of the statistically significant CCTs and perfusion parameters in predicting subsequent vasospasm. The maximum area under the curve of the ROC was used to determine optimal cutoff value. Significance was set to p < 0.05 for all statistical tests. Analyses were performed using SPSS® 20 (IBM-SPSS, Chicago, USA).
Results
The clinical symptoms and signs for all forty-one patients are summarized in Table 1. The mean time interval between the CTP and DSA scanning starts was 6.1 hours. The mean time interval between admission and vasospasm development was 7 ± 2.8 days. All of the treatments were smoothly. There were not significantly more subjects with higher Fisher grades in the vasospasm group than in the control group (p = 0.186). There was a significantly higher incidence of delayed cerebral ischemia in the vasospasm group (p <0.001). The ICCs for DSA-based TTP measurements between the two readers ranged from 0.92 to 0.98, and the ICCs for the CTP-based TTP measurements ranged from 0.85 to 0.99. The consistency of venous ROI placement and time measurement was not inferior to that of the arterial ROI in either the DSA or the CTP. Although there was less consistency for the DSA-based RA2 (ICC = 0.92) and CTP-based LM2 (ICC = 0.85) measurements, CCT measurement showed good consistency across the DSA- and CTP-based methods, with ICCs ranging from 0.96 to 0.98 (Table 2).
Table 1. Distribution of Patient Characteristics between control and vasospasm groups.
Control | Vasospasm | p† | |
---|---|---|---|
n | 19 | 22 | |
Sex (Male/Female) | 8/11 | 11/11 | 0.65 |
Age | 54.5 ± 15.3 | 61.4 ± 14.0 | 0.14 |
Initial GCS | 12.3 ± 3.9 | 10.3 ± 4.5 | 0.32 |
Fisher Grade (I/II/III/IV) | (6/6/1/6) | (5/2/2/13) | 0.186 |
Interval of two modalities | 5.8 ± 5.9 | 6.6 ± 5.4 | 0.72 |
Interval between admission and vasospasm | N/A | 7 ± 2.8 | N/A |
Delayed cerebral ischemia | 0 | 5 | <0.001 |
GCS = Glasgow Coma Scale.
† Mean comparisons were conducted using Student’s t-test for continuous variables and the Chi-square test for categorical variables.
Table 2. Intraclass-classification of Tmax in selected ROIs in DSA, TTP of selected ROIs in CTP, and calculated CCT.
TTP of ROI in DSA | ||||
Read A | Reader B | ICC | Range | |
RA2 | 3.3 ± 0.9 | 3.3 ± 0.9 | 0.92 | 0.82–0.96 |
RM2 | 3.5 ± 1.0 | 3.3 ± 1.0 | 0.96 | 0.92–0.98 |
LA2 | 3.1 ± 0.8 | 3.1 ± 0.7 | 0.97 | 0.97–0.99 |
LM2 | 3.2 ± 0.7 | 3.1 ± 0.7 | 0.98 | 0.96–0.99 |
RSSS | 9.5 ± 2.5 | 9.4 ± 2.5 | 0.98 | 0.97–0.99 |
LSSS | 9.2 ± 2.4 | 9.0 ± 2.4 | 0.95 | 0.88–0.97 |
TTP of ROI in CTP | ||||
Read A | Reader B | ICC | Range | |
A2 | 13.2 ± 4.7 | 13.2+4.1 | 0.99 | 0.99–0.99 |
RM2 | 14.3 ± 3.1 | 14.3 ± 4.0 | 0.91 | 0.81–0.96 |
LM2 | 13.7 ± 4.2 | 13.8 ± 4.0 | 0.85 | 0.81–0.95 |
CCT | ||||
Read A | Reader B | ICC | Range | |
XA-CCTRA2 | 5.7 ± 1.9 | 5.7 ± 1.8 | 0.97 | 0.94–0.99 |
XA-CCTRM2 | 5.9 ± 1.8 | 5.9 ± 1.9 | 0.97 | 0.94–0.99 |
XA-CCTLA2 | 6.0 ± 2.0 | 5.9 ± 1.9 | 0.96 | 0.91–0.98 |
XA-CCTLM2 | 5.9 ± 2.0 | 5.9 ± 2.0 | 0.97 | 0.94–0.98 |
CT-CCTA2 | 6.4 ± 2.1 | 6.4 ± 2.0 | 0.98 | 0.96–0.99 |
CT-CCTRM2 | 6.3 ± 2.0 | 6.3 ± 2.0 | 0.98 | 0.95–0.99 |
CT-CCTLM2 | 5.8 ± 2.0 | 5.9 ± 2.0 | 0.97 | 0.94–0.98 |
High and significant correlations were found between XA-CCT and CT-CCT based on the current ROI placements and time measurements (R2 ranged from 0.263 to 0.487) (Fig 3). The correlation coefficients were lowest for LA2 (r = 0.53), followed by LM2 (r = 0.62), RA2 (r = 0.64) and RM2 (r = 0.65), as arterial ROIs. None of the correlation for GCS and XA-CCT were significant (R2 ranged from 0.015 to -0.108 (Fig 4). Only CT-CCTLM2 showed a mild correlation with GCS (R2 = 0.108). Neither CT-CCTRM2 nor CT-CCTA2 were significantly correlated with GCS (Fig 5). Apart from XA-CCTLA2, the remaining angiographic and CT CCTs in the vasospasm group were significantly prolonged compared to those in the control group. For CTP, only MTT and TTP were significantly prolonged in the vasospasm group compared to the control group (Table 3). The ROC curves of XA-CCT, CT-CCT, MTT and TTP are provided in Fig 6. All CT-CCT measures displayed superior diagnostic accuracy compared to the XA-CCTs, and were followed by TTP and MTT in differentiating the vasospasm from control groups (Table 4).
Table 3. Different cerebral circulation times, and perfusion parameters between vasospasm and control groups.
Circulation Time | Control (N = 19) | Vasospasm (N = 22) | P |
XA-CCTRA2 | 4.9 ± 0.9 | 6.0 ± 1.3 | 0.08* |
XA-CCT LA2 | 4.6+1.0 | 5.8+2.4 | 0.055 |
XA-CCTRM2 | 4.7 ± 1.3 | 5.8 ± 2.1 | 0.045* |
XA-CCT LM2 | 4.9 ± 0.8 | 5.9 ± 2.1 | 0.05* |
CT-CCTA2 | 5.0 ± 2.6 | 6.4 ± 2.2 | 0.03* |
CT-CCTRM2 | 4.9+2.2 | 6.4+2.2 | 0.03* |
CT-CCT LM2 | 5.2 ± 2.1 | 6.7 ± 1.7 | 0.01* |
Perfusion | Control (N = 19) | Vasospasm (N = 22) | P |
CBV | 4.0 ± 1.6 | 3.3 ± 1.0 | 0.30 |
CBF | 30.0 ± 21.0 | 27.2 ± 17.4 | 0.35 |
MTT | 5.5 ± 1.1 | 6.3 ± 2.1 | 0.02* |
TTP | 15.1. ± 7.1 | 17.9 ± 3.1 | 0.02* |
* Student’s t-test p-value was less than 0.05.
Table 4. Optimal Cutoff Values of Ten all CCT, MTT, and TTP for Predicting Vasospasm.
ROI-variable | AUC | P | Optimal cutoff value | Sensitivity | Specificity |
---|---|---|---|---|---|
XA-CCTRA2 | 0.788(0.636–0.940) | 0.003* | 5.01 | 78.9% | 70.6% |
XA-CCT LA2 | 0.746(0.582–0.910) | 0.001* | 5.19 | 78.9% | 70.6% |
XA-CCTRM2 | 0.824(0.684–0.963) | 0.012* | 4.70 | 94.7% | 58.8% |
XA-CCT LM2 | 0.769(0.615–0.923) | 0.006* | 5.10 | 89.5% | 58.8% |
CT-CCTA2 | 0.851(0.710–0.993) | 0.000* | 5.62 | 84.2% | 82.4% |
CT-CCTRM2 | 0.837(0.694–0.981) | 0.001* | 5.32 | 94.7% | 70.6% |
CT-CCT LM2 | 0.824(0.674–0.974) | 0.001* | 5.35 | 94.7% | 64.7% |
CBV | 0.623(0.552–0.695) | 0.001* | 2.74 | 41.3% | 80.6% |
CBF | 0.627(0.555–0.698) | 0.001* | 34.35 | 65.9% | 60.2% |
MTT | 0.590(0.410–0.770) | 0.001* | 6.13 | 33.3% | 83.3% |
TTP | 0.778(0.630–0.925) | 0.001* | 17.3 | 52.2% | 94.0% |
*Student’s t-test p-value was less than 0.05.
Discussion
Although manual selection of ROIs is still needed in current versions of TDC analysis for both quantitative color-coded DSA and CTP, the consistency of inter-observer TTP ratings and calculated CCTs were reasonably high. In contrast to previous reports, we did not find inferior consistency in venous ROIs compared to arterial ROIs [21]. The cerebrovascular reserve and integrity of the circle of Willis might vary and change the CCT measurements [23–25]. The better correlations of measured AX-CCT and CT-CCT using ROIRA2 instead of ROILA2 are likely due to the higher incidence of hypoplasia of A1 in our study. The competing flows in the unilateral DSA series from the dominant (right) ACA via the anterior communicating artery would change the TDC waveform and subsequently decrease the accuracy of Tmax in ROIRA2 [21]. Although both used TDC to evaluate cerebral hemodynamics, the CTP was performed with intravenous administration of a bolus of contrast, whereas the DSA was administered via intra-arterial injection. Compared to intravenous injection, intra-arterial injection alters the waveform of the blood flow because of the power injector and thus does not perfectly represent physiologic flow. Nevertheless previous studies have shown that XA-CCT provides reliable hemodynamic monitoring [8–10]. In the current study, we found a high correlation between TDC with CTP (intra-venous injection) and DSA (intra-arterial injection), further supporting the feasibility of using CT-CCT as a surrogate to evaluate cerebral perfusion in SAH patients. This parameter is immediately available and free of variation from different perfusion software, and serves as an adjunct to CBF, MTT, TTP across different platforms [15, 26].
According to Sanelli et al, patients with lowered CBF, prolonged MTT and reduced CBF in CTP upon admission are predisposed to develop vasospasm later on. CBV and CBF have higher specificity (89–91%), but their sensitivities are low (36–50%). MTT has moderate specificity (70%) and sensitivity (61%). In contrast to previous studies, we did not find CBF to be a useful predictor of subsequent vasospasm [16]. Both MTT and TTP showed low sensitivity with high specificity in detecting vasospasm. A plausible explanation is that all CCTs, as well as TTP, were direct time-dependent variables and therefore were more sensitive to intravascular flow changes in response to constrictions of vessel walls in the early stage of vasospasm. MTT was calculated from deconvolution or the central volume principle to reflect the duration required for blood to go through the brain parenchyma, and thus was a mixed measurement of blood flow and “resistance” of the brain tissue [27]. The influence of different intervals in CCT and angiography was not validated in the current study. Given the internal interpolation algorithm used for TDC, we speculate that the influence of the acquisition interval is limited, but further study is needed for validation [28].
According to Krayenbűhl et al [9, 29], SAH patients with a circulation time of more than 5.5 s are considered to have developed a vasospasm. In our study, CCTs in the vasospasm group ranged from 5.9 to 6.5 s. Longer CCTs in our study resulted from our choice of using A2 and M2 as the arterial ROIs, and SSS as the venous ROI. The distance for the blood to travel was longer, compared to the distance from the cavernous portion of the internal carotid artery to the parietal vein in Krayenbűhl et al [29]. Iseda et al found a high correlation between CCT and SPECT, and their mean CCTs for the SAH patients with vasospasm was 4.1 seconds[13]. The shorter CCTs likely resulted from the shorter distance between the two reference points: the middle cerebral artery and cortical artery.
The low correlation between level of consciousness and XA-CCT or CT-CCT is probably due to several factors, including comorbid hydrocephalus, cerebral edema and fluctuations in the patients’ levels of consciousness between two examinations in the acute stage. The original Fisher grading system and its modified versions uses the distribution of SAH and IVH to evaluate the risk that patients will suffer delayed ischemic insult [30]. By using CCT measurement, the initial vascular response was quantified with a hemodynamic index. This index not only served as a predictor but also an indicator of vasospasm treatment results during the series follow-up [31].
Our study has several limitations. First, the study was retrospective, and the patient population was fairly small and limited to aneurysmal SAH patients with both CTP and DSA available. Therefore, potential lead-time bias and recall bias cannot be excluded. Second, the CTP coverage was smaller than that for DSA, thereby making it impossible to register all corresponding ROIs from the DSA in the CTP. Further studies using whole brain perfusion might optimize the comparison [32]. The overlapping anatomical structure in the two-dimensional DSA renders it impossible to correlate perfusion parameters between CTP and, for example, CBF with XA-CCT. Third, our study only revealed that intra-arterial and intra-venous injection protocols produced similar TDCs, but the interaction of heart rate and blood pressure on TDC was not made clear. Further studies using different FWHM time parameters, for example, maximum slopes, to elucidate mathematic relationships can improve the reliability of CBV by intra-arterial administration [33].
Struffert et al used dynamic scanning by flat-panel detectors to generate perfusion imaging and successfully detect perfusion deficits in acute stroke patients within the angiosuite [34]. This method can potentially monitor flow changes while treating patients with vasospasm by angioplasty or intra-arterial calcium channel blocker infusion. Nevertheless, compared to XA-CCA, this application required extra contrast injection for hemodynamic assessment. We confirmed that the TDC curves were similar for CTP and DSA, suggesting that intra-arterial protocols can successfully produce diagnostic images and can reduce contrast by 50% as well as reducing subsequent contrast-induced nephrotoxicity[35].
Conclusion
The similarity in TDCs between DSA and CTP can potentially help establish hemodynamic models with intra-arterial injections for flat-panel detector perfusion imaging. Like XA-CCT, CT-CCTs can be used in interpret cerebral flow without deconvolution algorithms, and outperform both both MTT and TTP in predicting vasospasm risk. This finding may help facilitate management of patients with SAH in the future when an appropriate prospectively study is performed that adequately addresses the relative risk and predictive values of these studies and algorithms for symptomatic vasospasm and delayed ischemic neurologic deficits.
Data Availability
All relevant data are within the paper.
Funding Statement
This research was co-sponsored by National Science Council of (grant number: MOST 104–2314–B–010–037) and Taipei Veterans General Hospital (VGHTPE) grant T1100200.
References
- 1.Molyneux AJ, Kerr RSC, Yu L-M, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488):809–17. Epub 2005/09/06. 10.1016/S0140-6736(05)67214-5 . [DOI] [PubMed] [Google Scholar]
- 2.Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJH, Rinkel GJE. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51(12):813–9. Epub 2009/07/23. 10.1007/s00234-009-0575-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Turowski B, du Mesnil de Rochemont R, Beck J, Berkefeld J, Zanella FE. Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty. Neuroradiology. 2005;47(2):134–43. Epub 2005/02/11. 10.1007/s00234-004-1281-4 . [DOI] [PubMed] [Google Scholar]
- 4.McGuinness B, Gandhi D. Endovascular management of cerebral vasospasm. Neurosurgery Clinics of North America. 2010;21(2):281–90. Epub 2010/04/13. 10.1016/j.nec.2009.10.007 . [DOI] [PubMed] [Google Scholar]
- 5.Jestaedt L, Pham M, Bartsch AJ, Kunze E, Roosen K, Solymosi L, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2008;62(3):610–7; discussion -7. Epub 2008/02/28. 10.1227/01.NEU.0000311351.32904.8B . [DOI] [PubMed] [Google Scholar]
- 6.Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke; a journal of cerebral circulation. 2009;40(6):1963–8. Epub 2009/04/11. 10.1161/STROKEAHA.108.544700 . [DOI] [PubMed] [Google Scholar]
- 7.Dankbaar JW, Rijsdijk M, Schaaf IC, Velthuis BK, Wermer MJH, Rinkel GJE. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51(12):813–9. 10.1007/s00234-009-0575-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Udoetuk JD, Stiefel MF, Hurst RW, Weigele JB, LeRoux PD. Admission angiogrpahic cerebral circulation time may predict subsequent angigroaphic vasospasm after aneurysmal subarachnoid hemorrhage Neurosurgery. 2007;61(6):1–10. [DOI] [PubMed] [Google Scholar]
- 9.Greitz T. A Radiologic Study of The Brain Circulation by Rapid Serial Angiography of the Carotid Artery. Stockholm: Acta Radiologica; 1956. [PubMed] [Google Scholar]
- 10.Lin C.-J., Chang F-C, Tsai F-Y, Guo W-Y, Hung S-C, Chen DY-T, et al. Stenotic Transverse Sinus Predisposes to Poststenting Hyperperfusion Syndrome as Evidenced by Quantitative Analysis of Peritherapeutic Cerebral Circulation Time. Am J Neuroradiol. 2014;35(6):1132–6. 10.3174/ajnr.A3838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lin CJ, Luo C-B, Hung S-C, Guo W-Y, Chang F-C, Beilner J, et al. Application of color-coded digital subtraction angiography in treatment of indirect carotid-cavernous fistulas: Initial experience. J Chin Med Assoc. 2013;76(4):218–24. 10.1016/j.jcma.2012.12.009 [DOI] [PubMed] [Google Scholar]
- 12.Aikawa H, Kazekawa K, Tsutsumi M, Onizuka M, Iko M, Kodama T, et al. Intraprocedural changes in angiographic cerebral circulation time predict cerebral blood flow after carotid artery stenting. Neurologia medico-chirurgica. 2010;50(4):269–74. Epub 2010/05/08. . [DOI] [PubMed] [Google Scholar]
- 13.Iseda T, Nakano S, Yoneyama T, Ikeda T, Moriyama T, Sameshima T, et al. Angiographic cerebral circulation time before and after endovascular therapy for symptomatic vasospasm. Clin Radiol. 2000;55(9):679–83. Epub 2000/09/16. 10.1053/crad.2000.0507 . [DOI] [PubMed] [Google Scholar]
- 14.Levitt MR, Morton RP, Haynor DR, Cohen W, Ghodke BV, Hallam DK, et al. Angiographic Perfusion Imaging: Real-Time Assessment of Endovascular Treatment for Cerebral Vasospasm. Journal of Neuroimaging. 2013;24(4):387–92. 10.1111/jon.12046 [DOI] [PubMed] [Google Scholar]
- 15.Greenberg ED, Gold R, Reichman M, John M, Ivanidze J, Edwards AM, et al. Diagnostic Accuracy of CT Angiography and CT Perfusion for Cerebral Vasospasm: A Meta-Analysis. Am J Neuroradiol. 2010;31(10):1853–60. 10.3174/ajnr.A2246 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sanelli PC, Ugorec I, Johnson CE, Tan J, Segal AZ, Fink M, et al. Using Quantitative CT Perfusion for Evaluation of Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage. Am J Neuroradiol. 2011;32(11):2047–53. 10.3174/ajnr.A2693 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kudo K, Sasaki M, stergaard LO, Christensen S, Uwano I, Suzuki M, et al. Susceptibility of Tmax to tracer delay on perfusion analysis: quantitative evaluation of various deconvolution algorithms using digital phantoms. Journal of cerebral blood flow and metabolism. 2011;31(3):908–12. Epub 2010/09/23. 10.1038/jcbfm.2010.169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Petralia G, Preda L, Raimondi S, D'Andrea G, Summers P, Giugliano G, et al. Intra- and Interobserver Agreement and Impact of Arterial Input Selection in Perfusion CT Measurements Performed in Squamous Cell Carcinoma of the Upper Aerodigestive Tract. Am J Neuroradiol. 2009;30(6):1107–15. 10.3174/ajnr.A1540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Straka M, Albers GW, Bammer R. Real-time diffusion-perfusion mismatch analysis in acute stroke. Journal of Magnetic Resonance Imaging. 2010;32(5):1024–37. Epub 2010/10/30. 10.1002/jmri.22338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke; a journal of cerebral circulation. 2000;31(7):1621–7. . [DOI] [PubMed] [Google Scholar]
- 21.Lin CJ, Hung SC, Guo WY, Chang FC, Luo CB, Beilner J, et al. Monitoring Peri-Therapeutic Cerebral Circulation Time: A Feasibility Study Using Color-Coded Quantitative DSA in Patients with Steno-Occlusive Arterial Disease. Am J Neuroradiol. 2012;33(9):1685–90. Epub 2012/04/14. 10.3174/ajnr.A3049 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Strother CM, Bender F, Deuerling-Zheng Y, Royalty K, Pulfer KA, Baumgart J, et al. Parametric Color Coding of Digital Subtraction Angiography. Am J Neuroradiol. 2010;31(5):919–24. Epub 2010/02/20. 10.3174/ajnr.A2020 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rim NJ, Kim HS, Shin YS, Kim SY. Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients. Am J Neuroradiol. 2008;29(9):1658–63. Epub 2008/07/12. 10.3174/ajnr.A1229 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Heyn C, Poublanc J, Crawley A, Mandell D, Han JS, Tymianski M, et al. Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease. Am J Neuroradiol. 2010;31(5):862–7. Epub 2010/01/16. 10.3174/ajnr.A1922 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N. Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. Am J Neuroradiol. 2004;25(2):242–7. Epub 2004/02/19. . [PMC free article] [PubMed] [Google Scholar]
- 26.Wintermark M, Ko NU, Smithh WS, Liu S, Higashida RT, Dillon WP. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. Am J Neuroradiol. 2006;27(1):26–34. Epub 2006/01/19. . [PMC free article] [PubMed] [Google Scholar]
- 27.Konstas AA, Goldmakher GV, Lee TY, Lev MH. Theoretic Basis and Technical Implementations of CT Perfusion in Acute Ischemic Stroke, Part 1: Theoretic Basis. Am J Neuroradiol. 2009;30(4):662–8. Epub 2009/03/10. 10.3174/ajnr.A1487 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Abels B, Klotz E, Tomandl BF, Villablanca JP, Kloska SP, Lell MM. CT Perfusion in Acute Ischemic Stroke: A Comparison of 2-Second and 1-Second Temporal Resolution. Am J Neuroradiol. 2011;32(9):1632–9. Epub 2011/08/06. 10.3174/ajnr.A2576 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.YM KH. Physiologie und Pathophysiologie der Hrindurchblutung Zerebrale Angiograophie Fur Klinik und Praxis 3rd edn. Stuttgart: Geroge Thieme; 1979. [Google Scholar]
- 30.Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid HemorrhageThe Fisher Scale Revisited. Stroke; a journal of cerebral circulation. 2001;32:2012–20. [DOI] [PubMed] [Google Scholar]
- 31.Connolly ES Jr., Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke; a journal of cerebral circulation. 2012;43(6):1711–37. Epub 2012/05/05. 10.1161/STR.0b013e3182587839 . [DOI] [PubMed] [Google Scholar]
- 32.Siebert E, Bohner G, Dewey M, Masuhr F, Hoffmann KT, Mews J, et al. 320-slice CT neuroimaging: initial clinical experience and image quality evaluation. The British journal of radiology. 2009;82(979):561–70. Epub 2009/02/18. 10.1259/bjr/27721218 . [DOI] [PubMed] [Google Scholar]
- 33.Figueiredo G, Boll H, Kramer M, Groden C, Brockmann MA. In vivo X-ray digital subtraction and CT angiography of the murine cerebrovasculature using an intra-arterial route of contrast injection. Am J Neuroradiol. 2012;33(9):1702–9. Epub 2012/05/12. 10.3174/ajnr.A3071 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Struffert T, Deuerling-Zheng Y, Kloska S, Engelhorn T, Lang S, Mennecke A, et al. Dynamic Angiography and Perfusion Imaging Using Flat Detector CT in the Angiography Suite: A Pilot Study in Patients with Acute Middle Cerebral Artery Occlusions. Am J Neuroradiol. 2015:Epub. 10.3174/ajnr.A4383 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Rosovsky M, Rusinek H. Dose-related nephrotoxicity. Radiology. 2006;240(2):614 Epub 2006/07/26. 10.1148/radiol.2402051816 . [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All relevant data are within the paper.